about
Cytoprotective role of heme oxygenase-1 in liver ischemia reperfusion injuryNew Therapeutic Concept of NAD Redox Balance for Cisplatin NephrotoxicityReactive oxygen species regulate protrusion efficiency by controlling actin dynamicsRegulation of drug-metabolizing enzymes by local and systemic liver injuriesSystems-scale analysis reveals pathways involved in cellular response to methamphetamineA novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cellsMechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.Metabolism of arachidonic acid by the cytochrome P450 enzyme in patients with chronic Keshan disease and dilated cardiomyopathy.Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemicsDetection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.Bcl-2 family proteins as regulators of oxidative stress.Cell biology of ischemia/reperfusion injury.Cytochrome P450 drives a HIF-regulated behavioral response to reoxygenation by C. elegans.Redox regulation of the immune response.Cytochrome P450 and myocardial ischemia: potential pharmacological implication for cardioprotection.N-acetylcysteine reduces markers of differentiation in 3T3-L1 adipocytes.Ischemia/Reperfusion.Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics.Convenient syntheses of [20,20,20-H(3)]-arachidonic acid and [20,20-H(2)]-20-hydroxyeicosatetraenoic acidInhibition of cardiac cytochrome P450: a new approach to cardiac ischaemia and reperfusion damage.Genome-wide analysis of low-dose irradiated male Drosophila melanogaster with extended longevity.Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection.Spectroscopic characterization of the iron-oxo intermediate in cytochrome P450.Thromboembolic and neurologic sequelae of discontinuation of an antihyperlipidemic drug during ongoing warfarin therapy.Assessment of effects of IR and IPC on activities of cytochrome P450 isozymes in rats by a five-drug cocktail approach.
P2860
Q26765308-E12AFA56-E151-4D8C-821D-91A8D39AF25AQ26765483-BC84EF2A-5542-49F9-A321-EE538E222FB0Q27332266-606BD1B3-9BC5-4D5E-9DBD-431B2A7257F8Q28067682-C782BC20-46F2-4491-8CD8-DCBB3D744C73Q28477826-3C253C4E-DE70-4842-84A8-9DC0176F0277Q33660799-5FAFE29B-B307-4C80-AE46-2F7C76264682Q35809644-153B2D22-1174-46E9-AE31-F4C06FE18D23Q36524657-ED1D4364-42CF-4CEA-9E49-29045ADAF76CQ36788554-B332E387-7749-40E2-96F9-2437CA603E17Q37355303-D9902FFB-AEF9-461F-97B6-3BDFA5FEAA02Q37367025-E9EE580D-FEC4-4091-93F7-10B120A1E7C0Q37524901-3859A15E-3B60-4FED-844D-E081BA8FAA0CQ37671643-EC424537-31CC-47E3-B0DE-18A9287C8BD5Q38100298-20C40384-D9FB-41D1-AD8F-4A9AABBD3DFDQ38225761-FDF5A0C3-A262-4CB6-AB38-A1D2FD614911Q38988014-26431E82-37BB-4BF1-B2A1-10DF2518935BQ39109413-557186DF-A165-46CC-BF46-7F5615303F68Q40456654-3D3D5A2E-F458-4264-B3D3-60C94AAACA74Q41915303-983EA496-A25F-4972-84DC-C9E8DDBE4F27Q45094114-D3A72505-F1BC-497A-A949-ACC96E3D7954Q45339997-EA7CB063-7501-42AA-8786-3CDF53338A70Q46743934-A20788B9-860D-4F22-9935-7CCB094BD7E5Q46747215-E107B994-0F36-4113-A8AB-5A56EBD2F447Q47108599-DDDC5D5A-BCA6-4490-8CA3-0B111880A81BQ48096883-38D8FAFF-D55F-49A7-B99A-44FE58F7FB12
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Cytochrome P450: major player in reperfusion injury.
@ast
Cytochrome P450: major player in reperfusion injury.
@en
type
label
Cytochrome P450: major player in reperfusion injury.
@ast
Cytochrome P450: major player in reperfusion injury.
@en
prefLabel
Cytochrome P450: major player in reperfusion injury.
@ast
Cytochrome P450: major player in reperfusion injury.
@en
P1476
Cytochrome P450: major player in reperfusion injury
@en
P2093
Roberta A Gottlieb
P304
P356
10.1016/J.ABB.2003.07.004
P407
P577
2003-12-01T00:00:00Z